| sumatriptan succinate / Generic mfg. |
NCT00847405: Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions |
|
|
| Completed | 1 | 28 | Canada | Sumatriptan Succinate, Imitrex® | Teva Pharmaceuticals USA | Healthy | 03/03 | 03/03 | | |
NCT00846885: Sumatriptan Succinate 100 mg Tablets Under Non-Fasting Conditions |
|
|
| Completed | 1 | 28 | US | Sumatriptan Succinate, Imitrex® | Teva Pharmaceuticals USA | Healthy | 09/04 | 10/04 | | |
NCT00650247: Food Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg |
|
|
| Completed | 1 | 57 | US | Sumatriptan Succinate Tablets 100 mg, Imitrex® Tablets 100 mg | Mylan Pharmaceuticals Inc | Healthy | 11/04 | 12/04 | | |
NCT00648466: Fasting Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg |
|
|
| Completed | 1 | 55 | US | Sumatriptan Succinate Tablets 100 mg, Imitrex® Tablets 100 mg | Mylan Pharmaceuticals Inc | Healthy | 12/04 | 12/04 | | |
NCT01269281: Bioequivalence Study of Sumatriptan Succinate Tablets 100 mg in Fed Conditions |
|
|
| Completed | 1 | 50 | RoW | Sumatriptan, Imitrex | Dr. Reddy's Laboratories Limited | Healthy | 07/05 | 07/05 | | |
NCT00614029: A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System |
|
|
| Completed | 1 | 54 | US | Sumatriptan (via Intraject System) | Zogenix, Inc. | Pharmacokinetics, Bioequivalence | 12/06 | | | |
NCT00546650: Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex® |
|
|
| Completed | 1 | 25 | US | Sumatriptan succinate | NuPathe Inc. | Healthy | 12/07 | 03/08 | | |
NCT00620425: A Study on the Effects of Repeat Doses of Intraject® Sumatriptan on Local Site Signs |
|
|
| Completed | 1 | 18 | NA | Sumatriptan, SUMAVEL(R) DosePro(R) | Zogenix, Inc. | Healthy | 12/07 | 12/07 | | |
NCT00701389: Study to Evaluate the Safety, Tolerability, and Blood Pressure Effect of an Oral Dose of Sumatriptan Alone and in Combination With MK-0974 (Telcagepant) in Migraine Patients (0974-026) |
|
|
| Completed | 1 | 24 | NA | telcagepant potassium, sumatriptan, sumatriptan placebo, telcagepant potassium placebo | Merck Sharp & Dohme LLC | Migraine Disorders | 04/08 | 04/08 | | |
NP101-006, NCT00720018: Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers |
|
|
| Completed | 1 | 4 | US | NP101 Sumatriptan Iontophoretic Transdermal Patch | NuPathe Inc. | Migraine Disorders | 07/08 | 07/08 | | |
NP101-011, NCT00723983: Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period |
|
|
| Completed | 1 | 23 | US | Sumatriptan succinate, NP101 Study Patch | NuPathe Inc. | Migraine Disorders | 09/09 | 09/09 | | |
NCT01381796: Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults |
|
|
| Completed | 1 | 63 | US | NP101, sumatriptan succinate, Imitrex | NuPathe Inc. | Compare Bioequivalence Patches Previously Used in the NP101-007 Study | 09/10 | 09/10 | | |
NCT01579383: Safety Tolerability and Pharmacokinetics of ALD403 |
|
|
| Completed | 1 | 104 | RoW | ALD403, Sumatriptan | Alder Biopharmaceuticals, Inc. | Migraine Disorders | 12/12 | 04/13 | | |
NCT02684409: Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine |
|
|
| Completed | 1 | 37 | US | PROT-CL-NP101-015.01, Zecuity®, Sumatriptan | NuPathe Inc. | Acute Migraine | 11/14 | 11/14 | | |
ACTRN12616000050459: Crossover Comparison of the Tolerability and Pharmacokinetics of ZP-Zolmitriptan Intracutaneous Microneedle System with Oral Zolmitriptan and Subcutaneous (SC) Sumatriptan in Healthy Volunteers |
|
|
| Completed | 1 | 20 | | | Pharmaceutical Solutions Ltd, Zosano Pharma, Inc. | Migraine | | | | |
PG-OCT, NCT02054299: Open Label Pharmacokinetic-Pharmacogenetic Study on Polymorphisms in the Organic Cation Transporter OCT1 |
|
|
| Completed | 1 | 48 | Europe | Drug application Amitriptyline, Drug application Desvenlafaxine, Drug application Sumatriptan, Drug application Proguanil, Drug application Fenoterol, Drug application Thiamine | University Medical Center Goettingen | Drug Metabolism, Membrane Transport | 02/16 | 02/16 | | |
NCT02741310: Study to Evaluate the Effect of Erenumab on Blood Pressure When Given Concomitantly With Subcutaneous Sumatriptan |
|
|
| Completed | 1 | 34 | Europe | Placebo, Sumatriptan, Imitrex™, Erenumab, AMG 334, Aimovig™ | Amgen | Healthy Subjects | 08/16 | 08/16 | | |
NCT03076970: Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants |
|
|
| Completed | 1 | 42 | US | lasmiditan 200 mg, LY573144, Sumatriptan, matching placebo | Eli Lilly and Company, SNBL Clinical Pharmacology Center, Inc., CoLucid Pharmaceuticals | Migraine | 04/17 | 04/17 | | |
NCT03310411: A Study of Lasmiditan When Given With Sumatriptan in Healthy Participants |
|
|
| Completed | 1 | 40 | US | Lasmiditan, LY573144, Sumatriptan, Placebo for Lasmiditan, Placebo for Sumatriptan | Eli Lilly and Company | Healthy | 12/17 | 12/17 | | |
| Completed | 1 | 19 | US | Sumatriptan Succinate Oral Tablet, Transdermal delivery of sumatriptan succinate, Sofusa DoseDisc, Sofusa DoseConnect, KC5010 | Sorrento Therapeutics, Inc., Kimberly-Clark Corporation | Migraine Disorders | 03/18 | 03/18 | | |
NCT02932488: Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation |
|
|
| Terminated | 1 | 17 | Europe | Sumatriptan, Imigran | Gitte Moos Knudsen | Healthy Volunteers | 06/19 | 06/19 | | |
NCT04355845: A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS. |
|
|
| Completed | 1 | 10 | US | Sumatriptan, PF-06651600 | Pfizer | Healthy Volunteers | 08/20 | 08/20 | | |
NCT04197349: Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman |
|
|
| Completed | 1 | 96 | RoW | ALD1910, Sumatriptan | H. Lundbeck A/S, Alder Biopharmaceuticals, Inc. | Migraine | 08/20 | 08/20 | | |
| Not yet recruiting | 1 | 12 | Europe | Sumatriptan 100 mg, Example of a brand name for sumatriptan: Migratan | Cambridge University Hospitals NHS Foundation Trust | Overweight | 06/21 | 06/21 | | |
| Completed | 1 | 40 | Europe | Evobrutinib, M2951, Digoxin, Metformin, Rosuvastatin, Sumatriptan | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Healthy | 12/21 | 12/21 | | |
